Fitsum G. E.
- Country
- France
- Department
- Nephrology
Research Overview
- Effect of Orforglipron on Major Adverse Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease
- A Phase 2b, Randomized, Controlled Double-blind, Multicenter Study Comparing the Efficacy and Safety of Zetomipzomib (KZR-616) 30 mg or 60 mg with Placebo in Patients with Active Lupus Nephritis
- Evaluation of Low-Dose Rivaroxaban for Cardiovascular Event Reduction in Patients with Advanced Chronic Kidney Disease or Dialysis Dependency
Data & Insights
Has run more than one trial at 130 of 692 partner sites.
Specializations
Chronic Kidney Disease Management
This investigator specializes in treating patients with advanced chronic kidney disease and its associated complications, with particular emphasis on hemodialysis optimization and innovative filtration techniques.
- Protein-bound uremic toxin clearance
- Cardiovascular complications in CKD
- Dialysis treatment optimization
Glomerular Diseases
The investigator focuses on treating various forms of glomerulonephritis, including specialized approaches for membranous nephropathy and IgA nephropathy.
- Personalized immunotherapy protocols
- Autoimmune kidney disorders
- Novel therapeutic approaches in nephropathy
Specialized Conditions
The investigator has expertise in managing rare and complex kidney disorders, including primary hyperoxaluria and lupus nephritis, employing targeted therapeutic strategies.
- Metabolic kidney disorders
- Hypertension management in kidney disease
- Novel therapeutic compounds
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.